HTLV infection in Brazil’s second-largest indigenous reserve
Amianti C, Bandeira L, Cesar G, Weis-Torres S, Tanaka T, Machado I, Gonçalves C, Simionatto S, Schnaufer E, Freitas F, Vallinoto A, Croda J, Motta-Castro A. HTLV infection in Brazil’s second-largest indigenous reserve. Scientific Reports 2022, 12: 16701. PMID: 36202887, PMCID: PMC9537150, DOI: 10.1038/s41598-022-21086-7.Peer-Reviewed Original ResearchConceptsHTLV infectionHTLV-1HTLV-2HTLV-1-associated myelopathyAdult T-cell leukemia/lymphomaHuman T-lymphotropic virus 1T-cell leukemia/lymphomaChronic inflammatory neurological diseaseHTLV-1 prevalenceInflammatory neurological diseasesHTLV-2 infectionAggressive malignant diseaseLeukemia/lymphomaEnzyme-linked immunosorbentMedian agePregnant populationMalignant diseaseBlood donorsStudy populationDrug usersNeurological diseasesCosmopolitan subtypeWestern blotSerum samplesDiseaseHuman T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study
Bandeira L, Puga M, Croda J, Pompílio M, Amianti C, de Rezende G, Motta-Castro A. Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study. Frontiers In Microbiology 2022, 12: 740245. PMID: 35126323, PMCID: PMC8815966, DOI: 10.3389/fmicb.2021.740245.Peer-Reviewed Original ResearchHTLV infectionCross-sectional studyEnzyme-linked immunosorbent assayHTLV-1New casesHuman T-lymphotropic virus (HTLV) infectionAnti-HTLV antibodiesHTLV proviral DNAProspective cohort studyWestern blot methodHarm reduction measuresBrazilian general populationHTLV transmissionCohort studyMulticenter studySerological evidenceVirus infectionPrevalence ratesHigh riskGeneral populationPreventive interventionsHTLV-2Risk behaviorsInfectionProviral DNA